Having trouble viewing this email? View it as a Web page. Removal of Foundayo from the Texas Medicaid Formulary Effective October 30, 2026 Due to an error, Foundayo tablet national drug codes (NDCs) was added to the formulary starting on September 29, 2026. As a result, HHSC Vendor Drug Program (VDP) will remove Foundayo from formulary as the drug is not eligible for addition to the Texas Medicaid Formulary. HHSC will remove the provisional coverage status for the following NDC in the table below, effective October 30, 2026.  NDC                                           Drug Name                                           00002417801  FOUNDAYO 0.8 MG TABLET  00002417831  FOUNDAYO 0.8 MG TABLET  00002450301  FOUNDAYO 2.5 MG TABLET  00002450331  FOUNDAYO 2.5 MG TABLET  00002479401  FOUNDAYO 5.5 MG TABLET  00002479431  FOUNDAYO 5.5 MG TABLET  00002480301  FOUNDAYO 9 MG TABLET  00002480331  FOUNDAYO 9 MG TABLET  00002483901  FOUNDAYO 14.5 MG TABLET  00002483931  FOUNDAYO 14.5 MG TABLET  00002495301  FOUNDAYO 17.2 MG TABLET  00002495331  FOUNDAYO 17.2 MG TABLET Other News October 2026 NDC-to-HCPCS Crosswalk Now Available for Clinician-Administered Drug Processing Agenda for Oct. 23, 2026, Drug Utilization Review Board Meeting Now Available Deadline Extended: Members Sought for the Drug Utilization Review Board; Applications Due Oct. 5 Outreach and Training Reminders Pharmacies Must Ensure Contact Information Is Current in PEMS Drug Shortage and Expedited Formulary, Preferred Drug List Addition Notification Available Texas Health Steps Includes Pharmacy Education Opportunities

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to ooseims.archieves@blogger.com using Granicus Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202